Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Dimitrios N. Sidiropoulos

Matched on ORCID iD 0000-0001-5716-3917; OpenAlex author ID A5053555298; NIH RePORTER profile ID 15317582. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
2
Labs led
1
Collaborators
51
Papers, trials and grants by year

2022: 1 paper · 2023: 1 grant · 2024: 4 papers · 2025: 1 paper · 2026: 3 papers, 1 grant

Papers 9

  1. First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. Co-author DOI 10.1158/2159-8290.cd-25-2245↗
  2. Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses. Co-author DOI 10.1158/2326-6066.cir-25-1126↗
  3. Deep Learning Enabled 3D Multi-Omic Analysis Reveals Molecular Signatures of Heterogeneous Response to Chemotherapy in Pancreatic Cancer Co-author DOI 10.64898/2026.03.03.709150↗
  4. CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial. Co-author DOI 10.1016/j.isci.2024.111569↗
  5. Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial. Co-author DOI 10.1038/s41467-024-52528-7↗
  6. Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic resp… Co-author DOI 10.1101/2024.09.22.613714↗
  7. Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Du… Co-author DOI 10.1158/0008-5472.can-23-1660↗
  8. Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci.insight.179292↗
  9. Inflammatory Signaling in Pancreatic Cancer Transfers Between a Single-cell RNA Sequencing Atlas and Co-Culture Co-author DOI 10.1101/2022.07.14.500096↗

Grants 2

  1. Decoding the clonal architecture and function of humoral immunity after immunotherapy in pancreatic adenocarcinoma K22CA315290↗
  2. Determining Dendritic Cell Responses to Vaccine-based Immunotherapy in PDAC at Single Cell Resolution. F31CA268724↗

Closest collaborators

The 25 strongest of 51 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elana Judith Fertig · 8 shared papers, 2022–2026 · strength 1.32
  2. Elizabeth M. Jaffee · 8 shared papers, 2022–2026 · strength 1.30
  3. Won Jin Ho · 7 shared papers, 2024–2026 · strength 1.28
  4. Luciane Tsukamoto Kagohara · 7 shared papers, 2022–2026 · strength 1.15
  5. Katherine M. Bever · 3 shared papers, 2024–2026 · strength 0.58
  6. Jacob T. Mitchell · 4 shared papers, 2022–2025 · strength 0.57
  7. Lei Zheng · 4 shared papers, 2022–2025 · strength 0.56
  8. Nicole Groß · 3 shared papers, 2024–2026 · strength 0.53
  9. Mark M. Yarchoan · 3 shared papers, 2024–2026 · strength 0.51
  10. Laura DeLong Wood · 3 shared papers, 2022–2026 · strength 0.47
  11. Hao Wang · 2 shared papers, 2026 · strength 0.42
  12. Jacquelyn W. Zimmerman · 3 shared papers, 2022–2025 · strength 0.41
  13. Dung Thi Le · 2 shared papers, 2024–2026 · strength 0.38
  14. Ashley L. Kiemen · 2 shared papers, 2024–2026 · strength 0.37
  15. Marina Baretti · 2 shared papers, 2024–2026 · strength 0.36
  16. Nilofer Saba Azad · 2 shared papers, 2024–2026 · strength 0.36
  17. Jae Woo Lee · 2 shared papers, 2024–2026 · strength 0.36
  18. Robert A. Anders · 2 shared papers, 2024–2025 · strength 0.31
  19. Janelle Marie Montagne · 2 shared papers, 2024–2025 · strength 0.31
  20. David Tsai Ting · 2 shared papers, 2022–2024 · strength 0.25
  21. Jin Peng He · 2 shared papers, 2022–2024 · strength 0.25
  22. Samantha R. Guinn · 2 shared papers, 2022–2024 · strength 0.25
  23. Toni T. Seppälä · 2 shared papers, 2022–2024 · strength 0.25
  24. Richard Andrew Burkhart · 2 shared papers, 2022–2024 · strength 0.25
  25. Jun Yu · 2 shared papers, 2022–2024 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.